医学
内皮
肾脏疾病
足细胞
病理
管周毛细血管
内皮干细胞
炎症
糖萼
肾功能
肾干细胞
血管生成
肾
内科学
免疫学
癌症研究
干细胞
蛋白尿
细胞生物学
体外
祖细胞
生物
生物化学
作者
Noémie Jourde‐Chiche,Fádi Fakhouri,Laetitia Dou,Jérémy Bellien,Stéphane Burtey,Marie Frimat,Pierre-André Jarrot,Gilles Kaplanski,Moglie Le Quintrec,Vincent Pernin,Claire Rigothier,Marion Sallée,Véronique Fremeaux‐Bacchi,Dominique Guerrot,Lubka T. Roumenina
标识
DOI:10.1038/s41581-018-0098-z
摘要
The kidney harbours different types of endothelia, each with specific structural and functional characteristics. The glomerular endothelium, which is highly fenestrated and covered by a rich glycocalyx, participates in the sieving properties of the glomerular filtration barrier and in the maintenance of podocyte structure. The microvascular endothelium in peritubular capillaries, which is also fenestrated, transports reabsorbed components and participates in epithelial cell function. The endothelium of large and small vessels supports the renal vasculature. These renal endothelia are protected by regulators of thrombosis, inflammation and complement, but endothelial injury (for example, induced by toxins, antibodies, immune cells or inflammatory cytokines) or defects in factors that provide endothelial protection (for example, regulators of complement or angiogenesis) can lead to acute or chronic renal injury. Moreover, renal endothelial cells can transition towards a mesenchymal phenotype, favouring renal fibrosis and the development of chronic kidney disease. Thus, the renal endothelium is both a target and a driver of kidney and systemic cardiovascular complications. Emerging therapeutic strategies that target the renal endothelium may lead to improved outcomes for both rare and common renal diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI